164 related articles for article (PubMed ID: 38725098)
1. Norepinephrine may promote the progression of
Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
[No Abstract] [Full Text] [Related]
2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
3. Autoinducer 2 of Fusobacterium nucleatum as a target molecule to inhibit biofilm formation of periodontopathogens.
Jang YJ; Choi YJ; Lee SH; Jun HK; Choi BK
Arch Oral Biol; 2013 Jan; 58(1):17-27. PubMed ID: 22633049
[TBL] [Abstract][Full Text] [Related]
4. Autoinducer-2 produced by oral microbial flora and alveolar bone loss in periodontitis.
Li C; Zhou H; Gou H; Fan Z; Zhang Y; Tang P; Huang J; Xu Y; Li L
J Periodontal Res; 2024 Jun; 59(3):576-588. PubMed ID: 38411269
[TBL] [Abstract][Full Text] [Related]
5.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
7. Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9/IL-1β signaling.
Wu J; Li K; Peng W; Li H; Li Q; Wang X; Peng Y; Tang X; Fu X
Int Immunopharmacol; 2019 Sep; 74():105724. PubMed ID: 31272064
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of autoinducer 2 of Fusobacterium nucleatum on oral streptococci.
Jang YJ; Sim J; Jun HK; Choi BK
Arch Oral Biol; 2013 Nov; 58(11):1594-602. PubMed ID: 24112724
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
10. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
11. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
12. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
13.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
14. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
15.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
16. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins.
Zanzoni A; Spinelli L; Braham S; Brun C
Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
18.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
19. D-Galactose as an autoinducer 2 inhibitor to control the biofilm formation of periodontopathogens.
Ryu EJ; Sim J; Sim J; Lee J; Choi BK
J Microbiol; 2016 Sep; 54(9):632-637. PubMed ID: 27572513
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
